Cytomegalovirus can cause permanent birth defects
The virus can show no symptoms in adults


Cytomegalovirus (CMV) recently caused a 2-month-old girl in Pennsylvania to suffer severe hearing loss after it was passed to her in the womb. While the virus can exist in a person for life without showing any symptoms, it can also cause permanent disability in infants. Researchers are looking to create a vaccine for the disease, but it has proven tricky.
What is CMV?
CMV is a common herpes virus. More than half of adults have been infected with CMV by age 40, most with no signs or symptoms, said the Centers for Disease Control and Prevention. Like most other herpes viruses, CMV tends to "establish lifelong latency," said the CDC. "Once a person becomes infected, the virus remains latent and resides in cells without causing detectable damage or illness." It can spread in adults through contact with infectious body fluids, sexual contact, organ transplants and blood transfusions. The virus is usually very mild in adults. However, it could be deadly for immunosuppressed people. In rare cases, some who acquire CMV infection "may experience a mononucleosis-like condition with prolonged fever and hepatitis."
In babies, it is the "leading infectious cause of birth defects in the United States," and can have lifelong complications, said CBS News. Infants can contract the virus in the uterus or during birth. It is symptomatic in 10% of cases and can lead to "jaundice, fever and enlargement of the spleen and liver," said Britannica. "Whether symptomatic or not, CMV infections are a major cause of congenital deafness and have other long-range neurological consequences, including intellectual disability and blindness."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"If it's very early in pregnancy, sometimes the result can be very serious," said Jennifer Vodzak, a pediatric infectious disease doctor at Nemours Children's Hospital, to CBS News. "It can lead to a miscarriage and sometimes very serious birth defects for an infant." New evidence also suggests that CMV may not be entirely harmless in adults, even if there are no visible symptoms. Reducing the burden of CMV on the immune system "may reduce cases of diabetes, heart disease and high blood pressure, particularly among non-Hispanic White (NHW) individuals," said a study published in the journal Lancet Regional Health.
What's the outlook for a vaccine?
Scientists are looking to develop a vaccine for CMV, though efforts have been unsuccessful. "If we don't know what weapons the enemy is using, it is hard to protect against it," said Jeremy Kamil, the senior author of a study about how CMV infects the body, in a statement. Luckily, the researchers have found a missing puzzle piece that represents one possible reason why immunization efforts against CMV have been so challenging.
The key is the virus' usage of a specific protein, which "becomes an alternative tool for breaking into cells lining the blood vessels and causing internal damage while simultaneously preventing the body's own immune system from recognizing the signs of infection," said the statement. "If we can develop antiviral drugs or vaccines that inhibit CMV entry, this will allow us to combat the many diseases this virus causes in developing babies and immune-compromised people," said Chris Benedict, the co-senior author of the study, in the statement. For now, newborn screening for the virus could allow for early intervention. Also, washing hands regularly and not sharing utensils, food or straws, especially when pregnant, can prevent the spread.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
September 27 editorial cartoons
Cartoons Saturday's political cartoons include Donald Trump and the rapture that wasn't
-
Sarah Ferguson: a reputation in tatters
In the Spotlight After emails surfaced revealing ties to Jeffrey Epstein, weeks after she claimed to cut contact, her charities are running for the hills
-
Sudoku medium: September 27, 2025
The Week's daily medium sudoku puzzle
-
Kissing bug disease has a growing presence in the US
The explainer The disease has yielded a steady stream of cases in the last 10 years
-
Private equity firms might be causing more deaths in hospital ERs
The Explainer Deaths in ERs purchased by private equity firms rose 13%
-
Why are autism rates increasing?
The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Why social media is obsessed with cortisol
In The Spotlight Wellness trend is the latest response to an increasingly maligned hormone
-
Scientists are speeding up evolution
Under the radar Proteins can evolve in minutes
-
Sloth fever shows no signs of slowing down
The explainer The vector-borne illness is expanding its range
-
A new subtype of diabetes was found and it may require different treatment
Under the radar It is prevalent in Black Africans and Americans